These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 33539920)
41. Amyloid-like aggregation of bovine serum albumin at physiological temperature induced by cross-seeding effect of HEWL amyloid aggregates. Nirwal S; Bharathi V; Patel BK Biophys Chem; 2021 Nov; 278():106678. PubMed ID: 34492451 [TBL] [Abstract][Full Text] [Related]
42. Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Li X; Koudstaal W; Fletcher L; Costa M; van Winsen M; Siregar B; Inganäs H; Kim J; Keogh E; Macedo J; Holland T; Perry S; Bard F; Hoozemans JJ; Goudsmit J; Apetri A; Pascual G Acta Neuropathol; 2019 May; 137(5):825-836. PubMed ID: 30805666 [TBL] [Abstract][Full Text] [Related]
43. The effect of fluorescent labeling on α-synuclein fibril morphology. Mučibabić M; Apetri MM; Canters GW; Aartsma TJ Biochim Biophys Acta; 2016 Oct; 1864(10):1419-27. PubMed ID: 27475048 [TBL] [Abstract][Full Text] [Related]
44. Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein. Landeck N; Strathearn KE; Ysselstein D; Buck K; Dutta S; Banerjee S; Lv Z; Hulleman JD; Hindupur J; Lin LK; Padalkar S; Stanciu LA; Lyubchenko YL; Kirik D; Rochet JC Mol Neurodegener; 2020 Sep; 15(1):49. PubMed ID: 32900375 [TBL] [Abstract][Full Text] [Related]
45. The effect of truncation on prion-like properties of α-synuclein. Terada M; Suzuki G; Nonaka T; Kametani F; Tamaoka A; Hasegawa M J Biol Chem; 2018 Sep; 293(36):13910-13920. PubMed ID: 30030380 [TBL] [Abstract][Full Text] [Related]
46. Defining an amyloid link Between Parkinson's disease and melanoma. Dean DN; Lee JC Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22671-22673. PubMed ID: 32868414 [TBL] [Abstract][Full Text] [Related]
47. De novo designed protein inhibitors of amyloid aggregation and seeding. Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734 [TBL] [Abstract][Full Text] [Related]
48. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods. Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601 [TBL] [Abstract][Full Text] [Related]
49. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity. Villar-Piqué A; Lopes da Fonseca T; Sant'Anna R; Szegö ÉM; Fonseca-Ornelas L; Pinho R; Carija A; Gerhardt E; Masaracchia C; Abad Gonzalez E; Rossetti G; Carloni P; Fernández CO; Foguel D; Milosevic I; Zweckstetter M; Ventura S; Outeiro TF Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6506-E6515. PubMed ID: 27708160 [TBL] [Abstract][Full Text] [Related]
50. The expression level of alpha-synuclein in different neuronal populations is the primary determinant of its prion-like seeding. Courte J; Bousset L; Boxberg YV; Villard C; Melki R; Peyrin JM Sci Rep; 2020 Mar; 10(1):4895. PubMed ID: 32184415 [TBL] [Abstract][Full Text] [Related]
52. Cross-Species and Cross-Polymorph Seeding of Lysozyme Amyloid Reveals a Dominant Polymorph. Rahimi Araghi L; Dee DR Front Mol Biosci; 2020; 7():206. PubMed ID: 32923456 [TBL] [Abstract][Full Text] [Related]
53. Differential effects of Cu Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541 [TBL] [Abstract][Full Text] [Related]
54. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term. Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768 [TBL] [Abstract][Full Text] [Related]
55. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking. Konno T; Morii T; Hirata A; Sato S; Oiki S; Ikura K Biochemistry; 2005 Feb; 44(6):2072-9. PubMed ID: 15697232 [TBL] [Abstract][Full Text] [Related]
56. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution. Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954 [TBL] [Abstract][Full Text] [Related]
57. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616 [TBL] [Abstract][Full Text] [Related]
59. Studies on alpha-synuclein and islet amyloid polypeptide interaction. Wang Y; Bergström J; Ingelsson M; Westermark GT Front Mol Biosci; 2023; 10():1080112. PubMed ID: 36793785 [No Abstract] [Full Text] [Related]
60. α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation. Vadukul DM; Papp M; Thrush RJ; Wang J; Jin Y; Arosio P; Aprile FA J Am Chem Soc; 2023 Aug; 145(33):18276-18285. PubMed ID: 37556728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]